checkAd

     202  0 Kommentare WISeKey selected by the German health tech company Digital Diagnostics AG to secure its digid cantisense SARS-CoV-2 test

    WISeKey selected by the German health tech company Digital Diagnostics AG to secure its digid cantisense SARS-CoV-2 test 

    Geneva – September 14, 2020 - WISeKey International Holding Ltd (“WISeKey”, SIX: WIHN / Nasdaq: WKEY), a leading cybersecurity and IoT company was selected by the German health tech company digid - Digital Diagnostics AG, to secure its digid cantisense SARS-CoV-2 test. 

    WISeKey cybersecurity and Identity Management is used to digitally certify and encrypt the data originated by a new type of sensor device from the German health tech company Digital Diagnostics AG that can be used for immediate tests for the new SARS coronavirus. The digid cantisense SARS-CoV-2 test becomes a pocket-sized laboratory and can be used in four steps anywhere on site by general practitioners, paramedics and nursing staff without much prior knowledge.

    The new rapid test detects antigens of SARS CoV-2 directly. Compared to previously known rapid tests, it reacts much better and leads to a clear electronic “YES” or “NO” statement regarding the presence of the virus in the test liquid. The results are available within five minutes; the time-consuming transport of the samples to the laboratory is no longer necessary.

    The new digital diagnostic platform enables the rapid testing of millions of people and thus enables real-time monitoring of the spread of the disease within the population. By connecting the digital sensor to a secure database, new regional hotspots of the virus spread can be recognized in real time and immediately contained.

    “This new win reinforces the overarching objective for WISekey is to establish a foothold into the Artificial Intelligence of Things (“AIoT”) market for health sector. This new segment, projected to bring over $10 million in revenue for WISeKey in calendar year 2021, compensates the loss of IoT revenue and maximizes near-term revenue, while at the same time creates significant market opportunities in the healthcare sector.  AI plays a growing role in IoT applications and deployments. Both investments and acquisitions in startups that merge AI and IoT have climbed over the past two years. The value of adding AI to the WISeKey platform is its ability to quickly gather insights from data. Machine learning, an AI technology, brings the ability to automatically identify patterns and detect anomalies in the data that smart sensors and devices gather such as temperature, pressure, humidity, air quality, vibration, and sound (and the above digid test..)”  said Carlos Moreira, CEO and Founder of WISeKey.

    Seite 1 von 4


    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    WISeKey selected by the German health tech company Digital Diagnostics AG to secure its digid cantisense SARS-CoV-2 test WISeKey selected by the German health tech company Digital Diagnostics AG to secure its digid cantisense SARS-CoV-2 test  Geneva – September 14, 2020 - WISeKey International Holding Ltd (“WISeKey”, SIX: WIHN / Nasdaq: WKEY), a leading …

    Schreibe Deinen Kommentar

    Disclaimer